Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026)
Ginkgo Bioworks Holdings posted quarterly Amortizatization of Intangibles of $7.1 million for Q1 2026, down 3.59% year-on-year from $7.4 million in Q1 2025, and down 6.8% on a QoQ basis from $7.6 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 5 years of Amortizatization of Intangibles data on file, last reported at $7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 3.59% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $29.8 million (changed 0.07% YoY), and the FY2025 full-year result was $30.1 million, up 7.07% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $7.1 million, down from $7.6 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $10.9 million in Q3 2022 and bottomed at $3.7 million in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $7.5 million (2025), against an average of $7.4 million.
- The widest annual swing landed in 2023, when Amortizatization of Intangibles slumped 48.95%; it then soared 103.26% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $7.2 million in 2022, then sank by 48.95% to $3.7 million in 2023, then jumped by 103.26% to $7.5 million in 2024, then rose by 2.1% to $7.6 million in 2025, then decreased by 6.8% to $7.1 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $7.1 million (Q1 2026), $7.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.11 Mn |
| Mar 31, 2026 | 7.11 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Jun 30, 2025 | 7.49 Mn |
| Jun 30, 2025 | 7.49 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 8.29 Mn |
| Jun 30, 2023 | 8.29 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 10.87 Mn |
| Sep 30, 2022 | 10.87 Mn |